首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1629831

日本內科治療設備市場 - 2024-2031

Japan Endotherapy Devices Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

日本腔內治療設備市場在 2023 年達到 27 億美元，預計到 2031 年將達到 44.4 億美元，2024-2031 年預測期間複合年成長率為 6.4%。

內視鏡設備是用於可視化和檢查內部器官和結構的醫療儀器，從而實現微創診斷和治療。它們在胃腸病學、肺病學、婦科和骨科等領域至關重要，可促進大腸鏡檢查、支氣管鏡檢查和腹腔鏡檢查等手術。高清和 3D 視覺化等影像技術的進步提高了準確性和精確度，減少了侵入性手術的需要並促進患者更快康復。

市場動態：

驅動程式和限制

內視鏡設備的技術進步

由於高清成像、3D 視覺化和人工智慧輔助診斷等技術進步，內視鏡設備市場正在成長。這些技術提高了內視鏡手術的精確度和效率，使醫生能夠更準確地檢測異常情況。人工智慧驅動的演算法增強了即時影像分析，識別表明癌症或息肉等疾病的模式。膠囊內視鏡為胃腸道診斷提供了一種對患者更友善的方法。靈活的機器人內視鏡提高了複雜手術中的可操作性和可及性，最大限度地減少組織創傷和恢復時間。

例如，2024年10月，奧林巴斯公司推出了智慧內視鏡生態系統，這是一個整合硬體、軟體、服務和資料的綜合醫療技術系統，以提高臨床決策和營運效率。

「智慧內視鏡生態系統」是對內視鏡未來的願景，專注於無縫通訊和智慧組件。該系統使用人工智慧演算法來改善患者治療效果和營運效率，使醫院和內科醫生受益。臨床環境中產生的數據和不同軟體的應用將增強系統的功能。

成本高且可近性有限

內視鏡設備和手術由於成本高而面臨嚴重的市場限制，這使得許多醫療機構難以承擔，特別是在低收入和中等收入國家。維護和維修費用也增加了財務負擔，限制了它們在資源有限的環境中的採用。缺乏熟練的專業人員來操作這些複雜的設備使問題更加複雜化，特別是在農村和服務不足的地區。這種差異導致診斷和治療延遲，對患者的治療結果產生負面影響。儘管努力開發具有成本效益的解決方案並培訓醫療保健專業人員，但這些挑戰仍然存在。

例如，基本內視鏡系統、雙極鉗主體系統和高速鑽主體系統的初始成本分別為4,500,000日元、3,500,000日元和3,035,000日元，不包括視訊設備。儘管成本效益高且以患者為中心的臨床結果，但醫院管理層仍難以適當地提供 FELD，儘管需要視訊設備和相容的視訊設備。

Endoscopy devices are medical instruments used to visualize and examine internal organs and structures, enabling minimally invasive diagnosis and treatment. They are crucial in fields like gastroenterology, pulmonology, gynecology, and orthopedics, facilitating procedures like colonoscopy, bronchoscopy, and laparoscopy. Advancements in imaging technologies, such as high-definition and 3D visualization, enhance accuracy and precision, reducing the need for invasive surgeries and promoting faster patient recovery.

Market Dynamics: Drivers & Restraints

Technological Advancements in Endoscopy Devices

The endoscopy devices market is growing due to technological advancements like high-definition imaging, 3D visualization, and AI-assisted diagnostics. These technologies improve the precision and efficiency of endoscopic procedures, enabling physicians to detect abnormalities more accurately. AI-powered algorithms enhance real-time image analysis, identifying patterns indicative of conditions like cancer or polyps. Capsule endoscopy offers a more patient-friendly approach to gastrointestinal diagnostics. Flexible robotic endoscopes improve maneuverability and accessibility in complex procedures, minimizing tissue trauma and recovery time.

For instance, in October 2024, Olympus Corporation introduced the Intelligent Endoscopy Ecosystem, a comprehensive medical technology system that integrates hardware, software, services, and data to improve clinical decision-making and operational efficiency.

The "Intelligent Endoscopy Ecosystem" is a vision for the future of endoscopy, focusing on seamless communication and intelligent components. This system uses AI algorithms to improve patient outcomes and operational efficiencies, benefiting hospitals and doctors in the endosuite. Data generated in clinical settings and the application of different software will enhance the system's capabilities.

High Costs and Limited Accessibility

Endoscopy devices and procedures face significant market restraint due to their high costs, which make them unaffordable for many healthcare facilities, especially in low- and middle-income countries. Maintenance and repair expenses also add to the financial burden, limiting their adoption in resource-constrained settings. The lack of skilled professionals to operate these sophisticated devices further complicates the issue, particularly in rural and underserved areas. This disparity results in delayed diagnoses and treatments, negatively impacting patient outcomes. Despite efforts to develop cost-effective solutions and train healthcare professionals, these challenges persist.

For instance, The initial costs for basic endoscope systems, bipolar forceps main body systems, and high-speed drill main body systems are ¥4,500,000, ¥3,500,000, and ¥3,035,000, respectively, excluding video equipment. Despite the high cost-effectiveness and patient-centered clinical outcomes, hospital management struggles to provide FELD appropriately, despite the need for video equipment and compatible video equipment.

Segment Analysis

The Japan endotherapy devices market is segmented based on product type, application and end user.

Product Type:

Endoscopes segment is expected to dominate the endotherapy devices market share

The endoscopes segment holds a major portion of the endotherapy devices market share and is expected to continue to hold a significant portion of the endotherapy devices market share during the forecast period.

Japan's endotherapy devices market is dominated by endoscopes, which are essential for minimally invasive medical procedures. With an aging population and increasing prevalence of gastrointestinal and chronic diseases, Japan has seen a surge in demand for endoscopic interventions. Endoscopes enable precise visualization and access to internal organs for diagnostic and therapeutic purposes, and are widely used in procedures like polypectomy, hemostasis, and stent placements. Japan's robust healthcare infrastructure and focus on preventive care have fueled the adoption of advanced endoscopic technologies, solidifying their crucial role in the nation's endotherapy devices landscape.

Moreover, novel product launches also help the segment to grow during the forecast period, for instance, in October 2024, Olympus has launched two bronchoscopes as part of its EVIS X1 Endoscopy System, which offers the latest in diagnostic and therapeutic bronchoscopy. The bronchoscopes feature slim outer diameters and large working channels, offering access to more distal airways. They are designed with high-definition imaging, allowing for improved suction and flexibility during procedures. The system also allows for the passage of a wide array of diagnostic and therapeutic devices through large working channels, providing physicians with options to successfully address the tracheal bronchial tree.

Gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share

The gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

Gynecology endoscopy is a key component in Japan's endotherapy devices market, focusing on advanced healthcare solutions for women's health. This minimally invasive technique is used for diagnosing and treating gynecological conditions like endometriosis, uterine fibroids, ovarian cysts, and infertility-related issues. With growing awareness of reproductive health and demand for early diagnosis, gynecological endoscopic procedures like hysteroscopy and laparoscopy have gained popularity. These procedures offer reduced pain, shorter recovery times, and minimal scarring, catering to Japan's aging and health-conscious population.

For instance, in September 2024, Olympus Corporation has launched a new 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Europe. The head is compatible with the VISERA ELITE III video system center for surgical endoscopy. The product will be launched in Japan, Hong Kong, and Singapore in September 2024, following regulatory compliance. The technical development was led by Sony Olympus Medical Solutions Corporation, a joint venture between Olympus and Sony Corporation.

Competitive Landscape

The major Japan players in the endotherapy devices market include Olympus Corporation, HOYA Corporation (Pentax Medical), Fujifilm Holdings Corporation, Sumitomo Bakelite Co., Ltd., Shinko Optical Co., Ltd, TOP Corporation, KARL STORZ Japan K.K., Nipro Corporation, Terumo Corporation, Hitachi Ltd. among others.

Emerging Players

The emerging players in the endotherapy devices market include JMS Co., Ltd, Matsunami Glass Ind., Ltd, Asahi Intecc Co., Ltd, Nissha Medical Technologies, Kuraray Co., Ltd, Sysmex Corporation among others.

Key Developments

In October 2023, Olympus has introduced its next-generation EVIS X1 endoscopy system for gastrointestinal practitioners, along with GIF-1100 and CF-HQ1100DL/I compatible endoscopes. The GIF-1100 is for the upper digestive tract, while the CF-HQ1100DL/I is for the lower digestive tract. The system received approval earlier this year.
In November 2023, Olympus Corporation has launched its next-generation EVIS X1 endoscopy system in China, marking its availability in all of Olympus' major markets. The advanced system, first released in Europe, Japan, and the U.S. in April 2020, has now received clearance in China, marking its first launch in China since its launch in Europe, Japan, and the U.S. in October 2023.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan endotherapy devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements in Endoscopy Devices
4.2. Restraints
- 4.2.1. High Costs and Limited Accessibility
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Endoscopes *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Endoscopic Operative Devices
6.4. Endoscopic Visualization Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Gynecology Endoscopy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gastrointestinal (GI) Endoscopy
7.4. Bronchoscopy
7.5. Urology Endoscopy
7.6. Arthroscopy
7.7. Laparoscopy

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Specialty Clinics

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Olympus Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. HOYA Corporation (Pentax Medical)
10.3. Fujifilm Holdings Corporation
10.4. Sumitomo Bakelite Co., Ltd.
10.5. Shinko Optical Co., Ltd.
10.6. TOP Corporation
10.7. KARL STORZ Japan K.K.
10.8. Nipro Corporation
10.9. Terumo Corporation
10.10. Hitachi Ltd

LIST NOT EXHAUSTIVE